Why do postmenopausal women discontinue hormone replacement therapy?

被引:51
作者
Vihtamäki, T [1 ]
Savilahti, R [1 ]
Tuimala, R [1 ]
机构
[1] Tampere Univ Hosp, Dept Obstet & Gynaecol, Tampere 33521, Finland
关键词
hormone replacement therapy; postmenopausal women; questionnaire; compliance;
D O I
10.1016/S0378-5122(99)00047-X
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objectives: To study the prevalence and acceptance of hormone replacement therapy (HRT) in the Finnish population and to ascertain the factors leading to premature discontinuation of HRT. Methods: A questionnaire survey was conducted among all women aged 50-60 selected from the age-sex register, 1065 women were identified and 884 (response rate 84%) agreed to participate. Results: 111 women were premenopausal and 773 postmenopausal; 302 (39%) were current HRT users, 126 (16%) previous users and 345 (45%) non-users. Of the previous users 27% had used oestrogen for less than 6 months and 46% had ceased treatment within 1 year. The main reason for discontinuation was side-effects; 41% of the women had suffered from them. Fear of cancer (16%), recommendation of a physician (12%), inefficiency (4%), and advice of a friend (3%) were other causes of discontinuation. Of the current users, 20% had continuous side-effects from the treatment and 15% had been advised to discontinue the treatment. Eleven percent of current users and 11% of previous users reported not having received any information about HRT. Conclusions: in this survey, more than half of postmenopausal women had used HRT at menopause. Every third of the women had discontinued the treatment, mainly because of side-effects but also because of fear of cancer and advice of physicians. (C) 1999 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:99 / 105
页数:7
相关论文
共 24 条
[11]  
LOBO RA, 1994, FERTIL STERIL S2, V62, P176
[12]  
Michaëlsson K, 1998, BMJ-BRIT MED J, V316, P1858
[13]  
NACHTIGALL LE, 1990, OBSTET GYNECOL, V75, P77
[14]   Hormone replacement therapy among Danish women aged 45-65 years: Prevalence, determinants, and compliance [J].
Oddens, BJ ;
Boulet, MJ .
OBSTETRICS AND GYNECOLOGY, 1997, 90 (02) :269-277
[15]   HAS THE CLIMACTERIC BEEN MEDICALIZED - A STUDY ON THE USE OF MEDICATION FOR CLIMACTERIC COMPLAINTS IN 4 COUNTRIES [J].
ODDENS, BJ ;
BOULET, MJ ;
LEHERT, P ;
VISSER, AP .
MATURITAS, 1992, 15 (03) :171-181
[16]   Estrogen replacement therapy and risk of Alzheimer disease [J].
PaganiniHill, A ;
Henderson, VW .
ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (19) :2213-2217
[17]  
Schneider HPG, 1997, INT J FERTIL WOMEN M, V42, P365
[18]   Womens attitudes and knowledge about the climacteric period and its treatment. A Swedish population-based study [J].
Stadberg, E ;
Mattsson, LA ;
Milsom, I .
MATURITAS, 1997, 27 (02) :109-116
[19]   A PROSPECTIVE-STUDY OF POSTMENOPAUSAL ESTROGEN THERAPY AND CORONARY HEART-DISEASE [J].
STAMPFER, MJ ;
WILLETT, WC ;
COLDITZ, GA ;
ROSNER, B ;
SPEIZER, FE ;
HENNEKENS, CH .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (17) :1044-1049
[20]   USE OF HORMONE REPLACEMENT THERAPY IN 1976-89 BY 45-64-YEAR OLD FINNISH WOMEN [J].
TOPO, P ;
KLAUKKA, T ;
HEMMINKI, E ;
UUTELA, A .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1991, 45 (04) :277-280